Rezolute, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Rezolute, Inc. (formerly AntriaBio, Inc.) on December 19, 2017. The report details a corporate restructuring event that became effective on December 18, 2017.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate name change and merger structure rather than financial performance.
Material Changes
- Merger Completion: The Company completed a parent/subsidiary merger with its wholly-owned subsidiary, Rezolute, Inc., under Section 253 of the Delaware General Corporation Law. The merger became effective at 11:59 p.m. on December 18, 2017.
- Name Change: Upon the effective time of the merger, the Company's name was officially changed from AntriaBio, Inc. to Rezolute, Inc.
- Stock Symbol Update: The Company's Common Stock was assigned a new trading symbol, "RZLT," for quotation on the OTCQB, effective at the opening of trading on December 19, 2017.
- CUSIP Update: The new CUSIP number for the Company is 76200L101.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. The document serves solely to disclose the completion of the merger and the associated administrative changes.
Investor Verification Checklist
- Verify the new stock ticker symbol "RZLT" on the OTCQB market.
- Confirm the new CUSIP number 76200L101 for trading and settlement purposes.
- Review the Company's Certificate of Incorporation to confirm the name change to Rezolute, Inc.
- Note that shareholder approval was not required for this specific merger under Delaware law.